1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Orticumab : the potential to harness oxidized LDL to reduce coronary inflammation with plaque-targeted therapy
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Atherogenesis and plaque rupture, surface/interface-related phenomena
(
- Contribution to journal › Article
- 2004
-
Mark
CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions
(
- Contribution to journal › Article
- 2001
-
Mark
Induction of CD36 by all-trans retinoic acid: retinoic acid receptor signaling in the pathogenesis of atherosclerosis
(
- Contribution to journal › Article